These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2017-000347-41 Safety of extended use of the weekly oral docetaxel formulation ModraDoc006/r in patients with advanced solid tumours Veiligheid van voortgaand gebruik van de wekelijkse orale docetaxel formulerin... bad-data
Listed as ongoing, but also has a completion date 2018-003249-41 A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane 2020-11-09 bad-data
Ongoing 2019-000582-21 A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane. not-yet-due